What happened
GeneOne Life Science updated the terms of a private placement (third-party allotment) to raise US$10.6M, about 30.9% of its market value.
For context, this raise equals about 30.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$10.6M |
| vs. market value | 30.9% |
| Filed | 2026-08-10, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260810000223 → open original filing |
Source: DART. Information only, not investment advice.